Abner Herrman & Brock’s Medtronic MDT Stock Holding History

Abner Herrman & Brock’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,829	Closed	-$203K	–	101
2022 Q1	$203K	Buy	+1,829	New	+$193K	0.03%	92
2021 Q4	–	Sell	-1,763	Closed	-$221K	–	106
2021 Q3	$221K	Hold	1,763	–	–	0.03%	86
2021 Q2	$219K	Sell	1,763 -33	-2%	-$4.14K	0.03%	89
2021 Q1	$212K	Sell	1,796 -13	-0.7%	-$1.52K	0.03%	91
2020 Q4	$212K	Buy	+1,809	New	+$199K	0.03%	106
2020 Q2	–	Sell	-2,266	Closed	-$204K	–	114
2020 Q1	$204K	Buy	+2,266	New	+$241K	0.05%	94
2016 Q4	–	Sell	-3,216	Closed	-$278K	–	125
2016 Q3	$278K	Buy	+3,216	New	+$280K	0.06%	99

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Abner Herrman & Brock's MDT Position: Q2 2022 in Review

Abner Herrman & Brock sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,829 shares — an estimated $203K sold.

Abner Herrman & Brock first reported a position in MDT in Q3 2016 and held it in 7 quarters. The position peaked at $278K in Q3 2016. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Abner Herrman & Brock reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
Abner Herrman & Brock sold 1,829 Medtronic shares in Q2 2022, an estimated $203K.
Abner Herrman & Brock first reported a position in Medtronic in Q3 2016 and held it in 7 quarters.
Abner Herrman & Brock's Medtronic position peaked at $278K in Q3 2016.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Abner Herrman & Brock's 13F filing for Q2 2022, filed 13 Jul 2022.